Literature DB >> 21987755

Ebola Reston virus infection of pigs: clinical significance and transmission potential.

Glenn A Marsh1, Jessica Haining, Rachel Robinson, Adam Foord, Manabu Yamada, Jennifer A Barr, Jean Payne, John White, Meng Yu, John Bingham, Pierre E Rollin, Stuart T Nichol, Lin-Fa Wang, Deborah Middleton.   

Abstract

In 2008, Reston ebolavirus (REBOV) was isolated from pigs during a disease investigation in the Philippines. Porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV-2) infections were also confirmed in affected herds and the contribution of REBOV to the disease outbreak remains uncertain. We have conducted experimental challenge studies in 5-week-old pigs, with exposure of animals to 10(6) TCID(50) of a 2008 swine isolate of REBOV via either the oronasal or subcutaneous route. Replication of virus in internal organs and viral shedding from the nasopharynx were documented in the absence of clinical signs of disease in infected pigs. These observations confirm not only that asymptomatic infection of pigs with REBOV occurs, but that animals so affected pose a transmission risk to farm, veterinary, and abattoir workers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987755     DOI: 10.1093/infdis/jir300

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  47 in total

1.  Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques.

Authors:  Kendra J Alfson; Laura E Avena; Michael W Beadles; Hilary Staples; Jerritt W Nunneley; Anysha Ticer; Edward J Dick; Michael A Owston; Christopher Reed; Jean L Patterson; Ricardo Carrion; Anthony Griffiths
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

2.  Global trends in infectious diseases at the wildlife-livestock interface.

Authors:  Anke K Wiethoelter; Daniel Beltrán-Alcrudo; Richard Kock; Siobhan M Mor
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-20       Impact factor: 11.205

3.  Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences.

Authors:  Serena A Carroll; Jonathan S Towner; Tara K Sealy; Laura K McMullan; Marina L Khristova; Felicity J Burt; Robert Swanepoel; Pierre E Rollin; Stuart T Nichol
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

4.  Ebola virus disease: history, epidemiology and outbreaks.

Authors:  Jacqueline Weyer; Antoinette Grobbelaar; Lucille Blumberg
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

5.  Genetic Changes at the Glycoprotein Editing Site Associated With Serial Passage of Sudan Virus.

Authors:  Kendra J Alfson; Laura E Avena; Michael W Beadles; Heather Menzie; Jean L Patterson; Ricardo Carrion; Anthony Griffiths
Journal:  J Infect Dis       Date:  2015-04-28       Impact factor: 5.226

6.  Reston virus causes severe respiratory disease in young domestic pigs.

Authors:  Elaine Haddock; Greg Saturday; Friederike Feldmann; Patrick W Hanley; Atsushi Okumura; Jamie Lovaglio; Dan Long; Tina Thomas; Dana P Scott; Mikayla Pulliam; Jürgen A Richt; Emmie de Wit; Heinz Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 11.205

Review 7.  Current ebola vaccines.

Authors:  Thomas Hoenen; Allison Groseth; Heinz Feldmann
Journal:  Expert Opin Biol Ther       Date:  2012-05-05       Impact factor: 4.388

8.  Ebola: facing a new transboundary animal disease?

Authors:  F Feldmann; H Feldmann
Journal:  Dev Biol (Basel)       Date:  2013-05-14

Review 9.  Neglected filoviruses.

Authors:  Robin Burk; Laura Bollinger; Joshua C Johnson; Jiro Wada; Sheli R Radoshitzky; Gustavo Palacios; Sina Bavari; Peter B Jahrling; Jens H Kuhn
Journal:  FEMS Microbiol Rev       Date:  2016-06-05       Impact factor: 16.408

10.  Determination and Therapeutic Exploitation of Ebola Virus Spontaneous Mutation Frequency.

Authors:  Kendra J Alfson; Gabriella Worwa; Ricardo Carrion; Anthony Griffiths
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.